Garfield Alastair
Rhythm Pharmaceuticals, Inc. · Chief Scientific Officer
Garfield Alastair is listed in public filings as officer: Chief Scientific Officer. This Garfield Alastair insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rhythm Pharmaceuticals, Inc. (RYTM). Investors use Garfield Alastair's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.5M25k shares | Grant / ExerciseFeb 11, 2026 | $2.5M25k shares | $98.47 | -- | |
| --16.7k shares | Grant / ExerciseFeb 11, 2026 | Disclosure amount unavailable16.7k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $846k7.8k shares | Grant / ExerciseFeb 1, 2026 | $220.8K2k shares | $108.99 | -- | |
| --9.8k shares | Grant / ExerciseFeb 1, 2026 | Disclosure amount unavailable6.7k shares | -- | -- | |
| $202k3.1k shares | SellJul 2, 2025 | $3886 shares | $64.60 | -- | |
| $203k3.1k shares | SellJul 2, 2025 | $85.1K1.3k shares | $64.81 | -- | |
| --4.4k shares | Grant / ExerciseJul 1, 2025 | Disclosure amount unavailable4.4k shares | -- | -- | |
| $2.3M40k shares | Grant / ExerciseFeb 14, 2025 | $2.3M40k shares | $56.69 | -- | |
| --26.7k shares | Grant / ExerciseFeb 14, 2025 | Disclosure amount unavailable26.7k shares | -- | -- |